Kansikuva näyttelystä Surgical Pioneering Podcast

Surgical Pioneering Podcast

Podcast by Dr. Reza Lankarani

englanti

Teknologia & tieteet

Sitten 7,99 € / kuukausi. Peru milloin tahansa.

  • Podimon podcastit
  • Lataa offline-käyttöön

Lisää Surgical Pioneering Podcast

"Surgical Pioneering Surgical Frontiers: Pioneering Tech Transforming Surgical Care" Mission Statement: Welcome to Surgical Frontiers, a global nexus for surgeons, researchers, engineers, and healthcare innovators dedicated to advancing surgical care through groundbreaking technology. This group is not just a platform—it’s a movement. Here, we explore, debate, and champion the innovations redefining the art and science of surgery. From AI-driven diagnostics to robotic-assisted procedures, augmented reality (AR) surgical navigation, and bioengineered implants, we are the vanguard of a new era in medicine. If you’re driven by curiosity, excellence, and the relentless pursuit of better patient outcomes, you belong here. --- Our Core Values: 1. Innovation First Surgery is no longer confined to scalpels and sutures—it’s a fusion of biology, engineering, and data science. We prioritize discussions on emerging technologies (e.g., nanorobotics, AI-powered predictive analytics, 3D bioprinting) and their real-world applications. Share prototypes, clinical trial results, or even bold hypotheses—if it pushes boundaries, we want to hear it. 2. Collaboration Over Competition Breakthroughs happen when diverse minds unite. Surgeons, engineers, ethicists, and entrepreneurs are all equal stakeholders here. Whether you’re a seasoned robotic surgeon or a startup founder developing smart OR tools, your perspective matters. Let’s dismantle silos and co-create solutions. 3. Evidence-Based Excellence Pioneering doesn’t mean reckless. We demand rigor. Posts about new tools or techniques should be grounded in peer-reviewed research, clinical data, or transparent case studies. Anecdotes are welcome, but they must spark deeper inquiry, not replace it. 4. Patient-Centric Ethics Technology is a means, not an end. Every innovation must answer: How does this improve patient safety, accessibility, or outcomes? We encourage tough conversations about cost, equity, and unintended consequences. Glorifying "tech for tech’s sake" has no place here. 5. Global Perspective Surgical challenges vary wildly between a high-resource urban hospital and a rural clinic. Share insights from low-income regions, disaster zones, or underserved communities. Innovation thrives when we solve for the margins, not just the mainstream. --- What You’ll Find Here : - Breakthrough Technologies: Deep dives into robotics, AI/ML applications, AR/VR surgical training, IoT-enabled devices, and beyond. - Expert Insights: Q&As with thought leaders, interviews with FDA regulators, and AMAs (Ask Me Anything) with pioneers. - Case Studies: How a hospital in Kenya adopted portable robotic tools, or how a Boston team used AI to reduce post-op infections by 40%. - Ethical Debates: Should AI diagnose surgical complications? Who owns data from smart implants? - Resource Sharing: Grants, conferences (e.g., SAGES, AACR), and regulatory updates. --- Why Join? - Learn: Weekly summaries of JAMA Surgery or Annals of Surgery highlights. - Influence: Shape the future by beta-testing tools, joining global consortia, or advising startups. - Grow: Mentorship threads for residents, grants for underrepresented innovators, and hackathons. --- The Future We’re Building: Imagine a world where: - A surgeon in Mumbai receives real-time AR guidance from a specialist in Toronto. - Bioprinted organs eliminate transplant waitlists. - AI predicts surgical complications before the first incision. "This isn’t science fiction—it’s the horizon we’re sprinting toward." Let’s pioneer responsibly. Let’s operate fearlessly. Post, comment, and collaborate. The next surgical revolution starts here. — Reza Lankarani M.D Founder & Curator, Surgical Frontiers "Surgical Pioneering Surgical Frontiers: Pioneering Tech Transforming Surgical Care" lankarani.substack.com

Kaikki jaksot

80 jaksot

jakson The Carter Ecosystem - Architecting the Future of Enterprise kansikuva

The Carter Ecosystem - Architecting the Future of Enterprise

Reviewed by Dr. Reza Lankarani [https://open.substack.com/pub/lankarani] 🫆 , General Surgeon Founder | Surgical Pioneering Newsletter and Podcast Series Editorial Board Member | Genesis Journal of Surgery and Medicine Medical Advisory Board Member | AIGENELAB.COM [http://AIGENELAB.COM] An In-Depth Analysis of the Strategic and Technological Impact of Christopher Carter [https://substack.com/profile/59481675-christopher-carter] on Global Enterprise Software, Artificial Intelligence, and Sustainable Infrastructure The global enterprise landscape is currently defined by a relentless drive toward digital transformation, a movement where legacy systems and modern cloud architectures must coexist to facilitate real-time decision-making. Central to the evolution of this ecosystem is Christopher Carter, a professional whose three-decade career serves as a blueprint for specialized entrepreneurship and technical innovation. As the founder of Approyo, Mugatu AI, and Charging Bunny, Carter has positioned himself at the nexus of several critical industry shifts: the migration of enterprise resource planning (ERP) systems to the cloud, the integration of predictive artificial intelligence within cybersecurity frameworks, and the decentralization of green energy through sustainable infrastructure. This report provides an exhaustive examination of Carter’s professional trajectory, the operational mechanics of his organizations, his contributions to technical literature, and the leadership philosophies that underpin his ventures in a rapidly shifting global economy. The Architectural Foundation: Education and Early Career Trajectory The professional narrative of Christopher Carter begins with a foundational commitment to the rigors of engineering and technology. His tenure at The Georgia Institute of Technology was the catalyst for his engagement with complex systems, providing the theoretical and practical groundwork required to navigate the high-stakes environment of enterprise software. Georgia Tech’s emphasis on technical precision and problem-solving became a defining characteristic of his subsequent career, particularly as he entered the SAP workforce during a period of significant growth for the German software giant. Following his graduation, Carter’s initial professional exposure was characterized by a blend of technical support and commercial operations. He worked within the SAP ecosystem before transitioning to a California-based startup, where he was tasked with managing day-to-day sales and marketing activities. This experience was instrumental in developing a holistic understanding of the technology sector; it required balancing the structural requirements of large-scale software with the agile, results-oriented demands of the venture-capital-backed startup world. The duality of this early career path—understanding both how technology is built and how it is sold—allowed Carter to move into multiple executive positions within the SAP ecosystem with a unique perspective on client needs and market gaps. Carter’s entrepreneurial journey was not a linear ascent but was informed by early ventures that provided essential lessons in both success and resilience. Before founding his current flagshiporganizations, he established an earlier business which he successfully scaled and eventually sold. However, this period of his life also included significant challenges, including the management of a company through bankruptcy. Far from being a deterrent, Carter characterizes the experience of bankruptcy as a formative period that sharpened his business instincts and fostered a level of resilience that would become a defining trait in his later career. This background underscores a broader entrepreneurial theme: the necessity of failure as a prerequisite for high-stakes success in the technology sector. Following the sale of his first company, Carter entered a brief period of retirement. This hiatus, however, was interrupted by the release of SAP HANA, a revolutionary in-memory database technology. Recognizing that HANA represented a fundamental shift in how data could be manipulated and utilized, Carter traveled to Germany to master the technology at its source. This deep dive into the technical core of SAP HANA provided the impetus for his return to the industry and the eventual founding of Approyo in December 2013. Approyo and the Specialization of SAP Cloud Services The founding of Approyo was a strategic response to a specific market ineficiency: the broad but shallow approach of many IT consulting firms. While many providers sought to manage multiple ERP systems simultaneously, such as Oracle, Microsoft Dynamics, and ServiceNow, Carter envisioned a firm that committed solely to the SAP ecosystem. This specialization was designed to position Approyo as a "true partner" for enterprises, ofering a depth of expertise that generalist firms could not replicate. The Business Model of Targeted Innovation Approyo operates primarily as an SAP Managed Service Provider (MSP), focusing on cloud-based solutions, migrations, and continuous hosting for global enterprises. The organization’s strategy is built upon the "platform ecosystem" trend, providing "ready to deploy" solutions that facilitate a seamless shift to the SAP HANA platform. This approach addresses a primary pain point for large organizations: the perceived risk and long timelines associated with migrating core business processes to the cloud. By utilizing a Platform-as-a-Service (PaaS) model, Approyo can launch a full SAP system in hours rather than the weeks or months typically required in legacy environments. The organizational identity of Approyo is further distinguished by its creative branding. The company’s name is a tribute to Bronson Arroyo, a Major League Baseball player and musician,reflecting Carter’s personal interests and a desire for an identity that stands out in a crowded technology market. Furthermore, Carter utilizes the "Alice in Wonderland" metaphor—encouraging clients to "go down the rabbit hole"—to describe the leap of faith required for digital transformation. This thematic approach humanizes the often intimidating process of technical migration, framing it as an explorative journey into the possibilities of Big Data and the cloud. Global Expansion and the "Follow the Sun" Model Since its inception in Muskego, Wisconsin, Approyo has grown into an international entity with approximately 173 employees as of early 2024. The firm has strategically expanded its reach into Brazil, the United Kingdom, Spain, and India, creating a global talent pool that allows for 24/7 support across multiple time zones. This expansion ensures that the company always has the right resources available for its clients, regardless of their geographical location or the time of day. This global footprint is more than a byproduct of growth; it is a core component of the "Follow the Sun" operational model. By distributing technical expertise across several continents, Approyo mitigates the risks of service interruption and provides clients with the "sleep well at night" assurance that is central to Carter’s leadership philosophy. The ability to tap into diverse technical talent in regions like India and Brazil has been described by Carter as a "game changer," allowing the firm to scale rapidly while maintaining a high standard of service. The Convergence of ERP, AI, and Cybersecurity: The Overwatch Paradigm As enterprises transitioned their most sensitive financial and operational data to the cloud, the need for proactive security measures became paramount. Carter recognized that traditional, reactive IT support was insuficient for the modern landscape. In response, he championed the development of Overwatch, an AI-powered monitoring and support platform that has become a cornerstone of Approyo’s value proposition. Technical Mechanics of Overwatch Overwatch is an integrative AI tool implemented on every client landscape Approyo manages. It is designed to provide proactive insights by understanding how a system will run in the coming weeks and identifying potential vulnerabilities before they can be exploited. The platform monitors not just SAP systems but also Oracle, other ERP platforms, and various cloudenvironments, creating a comprehensive security and performance layer. The financial and operational significance of Overwatch is substantial, with the proprietary technology represented as having a net worth of millions of dollars. Its primary functions include: ● Predictive Analytics: Analyzing historical data to forecast future system performance and hardware needs. ● Security Monitoring: Identifying vulnerabilities and proactively alerting administrators to potential breaches or disruptions. ● Operational Eficiency: Allowing companies to grow their SAP landscapes without the need for extensive new code or a significant increase in headcount. ● Cost Reduction: Optimizing cloud resources to control "cloud sprawl" and ensure that IT investments drive growth rather than just expense. This proactive stance is particularly critical in an environment where 89% to 93.7% of all global finances flow through SAP systems. Any interruption in these systems can lead to massive revenue loss, making predictive tools like Overwatch essential for business continuity. Mugatu AI and Defensive Intelligence Building on the success of Overwatch, Carter launched Mugatu AI as a dedicated venture to provide AI-based predictive analytics for security disruptions. Mugatu AI wraps around existing enterprise systems to provide a defensive layer that anticipates risks. The mission of Mugatu AI is to redefine leadership in an AI-driven world, providing tools that empower teams and drive innovation while maintaining a robust security posture. Mugatu AI focuses on the intersection of management and technical support, helping organizations bridge the gap between their cybersecurity maturity and the confidence of the C-suite and board of directors. Carter’s work with Mugatu AI emphasizes that AI is not merely a tool for automation but a strategic asset that can transform tech expenses into profitable investments by minimizing downtime and maximizing system reliability. Sustainability and Innovation: The Charging Bunny Initiative A recurring theme in Christopher Carter’s career is the identification of aging or ineficient infrastructure and the application of modern technology to solve those problems. This is most evident in the launch of Charging Bunny, a venture focused on the renewable energy and electric vehicle (EV) sectors. Addressing Grid Dependency Charging Bunny was born from Carter’s observation of the expanding EV market and the limitations of the existing electrical grid. He noted that much of the machinery in the traditional power industry is outdated and ill-equipped to handle the surging demand for EV charging points. To address this, Charging Bunny ofers solar-powered charging stations that operate independently of the grid. These standalone units utilize Tesla battery packs and charging solutions, providing a self-sustaining environment that does not rely on traditional power infrastructure.Investment and Creative Strategy Carter serves as the lead investor and the primary creative force behind Charging Bunny, having self-funded the venture to maintain control over its development and innovation. This "investor-creative" role allows for a rapid development cycle, as the company is not beholden to external funding requirements or the slow decision-making processes often found in large energy firms. The launch of Charging Bunny represents a second-order insight into Carter’s professional strategy: he leverages his expertise in "Big Data" and AI to manage and optimize green energy systems, efectively cross-pollinating lessons from the ERP world into the sustainability sector. This venture demonstrates that the future of enterprise leadership belongs to those who embrace disruption across multiple domains, rather than remaining siloed in a single industry. Literary Contributions and Knowledge Distribution Christopher Carter is a prolific author and a recognized thought leader, having written 17 books and achieved four-time best-seller status on Amazon. His literary work is a critical component of his mission to simplify technology and empower the next generation of technologists. The "Mastering SAP" Series His flagship series, "Mastering SAP," is widely regarded as a definitive resource for organizations looking to optimize their usage of the platform. The series covers a range of topics from technical implementation to high-level business strategy. Key titles in the series include: ● Mastering SAP: The Power of AI in Business - How to Use AI with SAP: A bestseller that provides a roadmap for leveraging artificial intelligence to strengthen SAP operations. ● Mastering SAP: The Power of Cloud with SAP: Detailing the benefits and challenges of migrating ERP landscapes to cloud environments. ● Mastering SAP: Protecting your SAP environment in Today’s Cybersecurity World: A comprehensive guide to identity and access management, GRC (Governance, Risk, and Compliance), and multi-layered security in the SAP ecosystem. ● Mastering SAP: A Comprehensive Guide: A broad overview of the platform’s capabilities and its role in modern finance and operations. Carter’s books are not merely commercial products; they are central to his philanthropic eforts. He frequently gives his books away to university students and members of the American SAP User Group (ASUG), choosing to focus on the development of young technologists rather thanthe promotion of his own company. Contributions to AI and Emerging Tech Literature Beyond SAP, Carter has authored several books specifically on the technical and philosophical aspects of artificial intelligence. These include: ● AI Algorithm Book: A deep dive into the mathematical and logical structures that underpin modern AI systems. ● AI Unleashed Profiles: Case studies and profiles of AI implementation across various industries. ● Small Language Models versus Large Language Models: A comparative analysis of the eficiency and utility of diferent AI architectures for specific business needs. This extensive body of work establishes Carter as more than an entrepreneur; he is an educator who seeks to bridge the gap between complex technical concepts and practical business application. Leadership Philosophy and Organizational Culture The organizational culture at Approyo and Carter’s other ventures is characterized by a "people-first" philosophy that prioritizes trust, empathy, and professional development. This approach is rooted in Carter’s personal history and his belief that while technology evolves, the human element remains the heart of any successful business. The "Hand Backwards" Principle One of Carter’s most prominent leadership principles is the idea of "having your hand backwards" while climbing the ladder of success. This concept emphasizes the responsibility of successful leaders to help those coming up behind them. This is manifested in his extensive mentoring of students and his membership in the Forbes Coaches Council, where he contributes expertise on leadership and business growth. Resilience and Adversity Carter’s leadership style is also informed by the adversity he faced as a young man. Growing up in a household characterized by divorce and financial instability—including periods of sleeping on couches and reliance on welfare—he developed a fierce determination to support himself and his family. He uses these experiences to motivate both his staff and the young people he mentors, teaching them that passion and grit are more important than the skills learned from abook alone. Industry Recognition and Global Influence The impact of Christopher Carter’s work is reflected in a long list of awards and accolades from major technology and business publications. He is frequently cited as a transformational leader who has redefined the role of a CEO in the enterprise software space. Recognition of Expertise ● Top SAP Expert: Industry Era recognized him as "One of the top 10 SAP experts in the world". ● Industry Influencer: Mirror Review named him "One of America’s Top 10 Industry Influencers" and "One of the Top 20 Business Leaders to Follow in SAP". ● Inc. 500/5000 Honoree: Both Approyo as a firm and Carter as a leader have been recognized on these prestigious lists of high-growth companies. ● ACQ Award: Winner of the ACQ award for excellence in SAP services. ● Revolutionary CEO: Aspioneer Magazine awarded him the title of "Revolutionary CEO of the Year". Media Presence and Thought Leadership Carter is a "Go-To" contributor for Newsmax-TV on technology topics and has had his advice featured in a wide array of publications, including Inc., Forbes, ASUG.com, TechTarget, Entrepreneur, and CRN. He is also a regular on the podcast circuit, appearing on programs like "The Tech'o'Space Podcast," "Smart Cherrys Thoughts," and "Concrete Build Crypto Financing," where he discusses the intersection of SAP, AI, and emerging technologies like blockchain and cryptocurrency. His membership in organizations like the American SAP User Group (ASUG), Hadoop World, and Cloud Expo further cements his role as a central figure in the technical community. Carter’s ability to speak on diverse topics—ranging from selective Go-Live and Big Data to the role of AI in real estate tokenization—illustrates his reach as a "visionary" who can connect disparate technologies into a cohesive strategy for growth. The Sherpa Trails and Personal Passions Beyond the corporate boardroom and the data center, Carter is an avid mountaineer, a passion that he has documented in his book entitled "Sherpa Trails". This interest in summiting mountains serves as a metaphor for his professional life: a series of dificult climbs that require preparation, endurance, and a reliable team. He often draws parallels between the discipline of high-altitude climbing and the persistence required to navigate the complexities of digital transformation. Additionally, Carter is a deep enthusiast of music, which he describes as his "outlet" from the high-pressure world of technology. This multifaceted personality—as an author, an athlete, a musician, and a technologist—contributes to a leadership style that is grounded and relatable, helping to build a "human core" within his organizations. Conclusion: Synthesis and Future Outlook Christopher Carter’s professional journey serves as a case study in the power of specialization, resilience, and the proactive integration of emerging technologies. By focusing exclusively on the SAP ecosystem, he transformed Approyo from a small consultative firm into a global managed services powerhouse that sits at the nexus of cloud innovation and enterprise stability. His development of proprietary AI tools like Overwatch has moved the industry toward a model of predictive, "hyper-aggressive" system support, ensuring that global financial transactions remain secure and eficient. The diversification of his portfolio into Mugatu AI and Charging Bunny demonstrates a forward-looking strategy that anticipates the next major shifts in the global economy: the need for advanced defensive intelligence and the decentralization of sustainable energy infrastructure. Carter’s work in these fields is linked by a common thread: the belief that every challenge—whether it is an aging electrical grid or a complex ERP migration—carries the "seed of reinvention." As 2026 approaches, Carter’s vision for his collective enterprises remains clear: to expand global operations, continue innovating with AI-driven solutions, and foster a leadership culture that empowers the next generation of technologists. His legacy is defined not just by the companies he has founded or the awards he has won, but by the "hand backwards" he has extended to others, ensuring that as technology evolves, the people at the heart of the business remain the priority. The integration of predictive intelligence with sustainable infrastructure and human-centric leadership positions Carter as a pivotal figure in the ongoing transformation of the global enterprise landscape. To access additional details, please refer to the Surgical Pioneering Podcast Series application available at the following link: https://Surgicalpioneer.codeadx.me [https://Surgicalpioneer.codeadx.me] Get full access to Reza Lankarani at lankarani.substack.com/subscribe [https://lankarani.substack.com/subscribe?utm_medium=podcast&utm_campaign=CTA_4]

6. tammi 2026 - 4 min
jakson Top 2025 Surgery Articles Analysis by Surgical Pioneering kansikuva

Top 2025 Surgery Articles Analysis by Surgical Pioneering

Reviewed by Dr Reza Lankarani [https://substack.com/profile/331286061-reza-lankarani], General Surgeon Founder | Surgical Pioneering Newsletter and Podcast Series Editorial Board Member | Genesis Journal of Surgery and Medicine These sources summarize prominent surgical research and academic analyses scheduled for publication in 2025, primarily from the JAMA Surgery and the Briti sh Journal of Surgery. The collection highlights technological advancements in the field, such as the use of novel fluorophores for nerve visualization and the efficacy of robotic-assisted procedures. Several clinical trials evaluate postoperative recovery strategies, comparing the performance of synthetic versus biological meshes and testing personalized prehabilitation programs for frail patients. Beyond clinical data, the documents explore historical perspectives on surgical tools, methodological guides for big-data research, and practical advice for surgeons seeking patents. Collectively, these articles establish new benchmarks for quality improvement and evidence-based standards across various minimally invasive and oncological specialties. Introduction: Question Everything You Think You Know About Surgery Medicine is a field of constant evolution. What is considered standard practice one day can be challenged and overturned by new evidence the next. Long-held beliefs and "common sense" assumptions about what works best in the operating room are continuously put to the test by rigorous scientific research. It is through this process—the willingness to question, test, and adapt—that true progress is made. This article explores five of the most surprising, counter-intuitive, and impactful findings from top surgical journals in 2025. From the hidden risks of advanced robotics to the dramatic failure of a "natural" alternative, these studies challenge our assumptions and are actively changing the future of surgery. The Five Most Surprising Surgical Findings of 2025 Finding 1: The 'Better' Robotic Surgery Has a Hidden Risk. The widespread perception of robot-assisted surgery is that it represents the safest, most advanced, and superior form of minimally invasive procedures. The precision and enhanced visualization offered by robotic platforms have made them an increasingly popular choice for a wide range of operations. However, a large international cohort study of 2,738 patients delivered a counter-intuitive finding: robot-assisted abdominal surgery was associated with a higher incidence of postoperative pulmonary complications compared to conventional laparoscopic surgery. The study identified the longer duration of the procedure under anesthesia as the primary driver of this increased risk. This finding provides a crucial piece of real-world evidence that challenges the assumed superiority of robotic platforms in every scenario. It doesn't negate the benefits of robotic surgery, but it underscores the critical importance of optimizing operative time and refining anesthetic and ventilation strategies during these longer procedures. This forces a more nuanced conversation about when and how robotic platforms should be used to ensure the best possible patient outcomes. Finding 2: The 'Natural' Choice for Hernia Repair Was a Dramatic Failure Inguinal hernia repair is one of the most common surgical procedures performed worldwide. In recent years, the idea of using a "biologic" mesh derived from animal tissue has held an intuitive appeal. The logic was that a more natural, absorbable material might integrate better with the body and cause less long-term pain than a permanent synthetic mesh. The BIOLAP randomized clinical trial put this logic to a direct, head-to-head test with stunning results. In this trial, 491 patients received both mesh types and were followed closely. The study found that the biologic mesh offered no advantage in postoperative pain. More alarmingly, it resulted in a dramatically higher rate of hernia recurrence at the two-year mark—11.2% for patients with biologic mesh versus just 2.5% for those with synthetic mesh. The verdict from the medical community was decisive, as synthesized in the study's editorial commentary: These results decisively counter the hypothesized advantages of biologics, reinforcing that synthetic mesh remains the undisputed standard of care based on robust, head-to-head evidence. Finding 3: A Good Idea Isn't Enough—Execution Is Everything The concept of "prehabilitation" is both logical and well-intentioned: why not strengthen frail, older patients before a major operation to help them recover better afterward? This approach aims to build up a patient's physiological reserve to better withstand the stress of surgery .But does it work? The evidence from 2025 is mixed and reveals a crucial lesson. One rigorous, multicenter trial of a coach-supported, home-based program for frail older adults found that it failed to improve primary outcomes compared to usual care. In contrast, another trial that tested a personalized prehabilitation regimen found measurable benefits, including improved immune parameters and slightly better functional recovery. The lesson isn't that prehabilitation "doesn't work," but that how we implement it is critical. These studies suggest a one-size-fits-all approach may be insufficient for vulnerable patients, while a tailored, personalized intervention shows real promise. It's a powerful reminder that in medicine, good intentions must be backed by data, and execution is everything. Finding 4: Minimally Invasive Surgery Is Now Ready for Advanced Cancer A core surgical assumption has long been that advanced cancers—like a T4a gastric cancer that has grown through the stomach wall—require a large, open incision. The traditional belief was that only an open approach could guarantee the visibility and access needed to remove the entire tumor safely and completely. The UMC-UPPERGI-01 trial directly challenged this dogma. Researchers compared laparoscopic versus open surgery for these advanced gastric cancer cases and found that the short-term outcomes were statistically equivalent. This included key metrics like 90-day complications and, most importantly, oncologic clearance (the ability to remove all cancerous tissue with clean margins). This high-quality evidence signals a major shift in surgical oncology. It demonstrates that, in experienced hands, a minimally invasive approach can be used safely for even advanced tumors. This finding has the potential to allow more patients to benefit from the faster recovery associated with laparoscopic surgery without compromising their cancer control. Finding 5: A Gene Test Can Spare Patients from Unnecessary Surgery For many patients diagnosed with melanoma, the standard process includes a sentinel lymph node biopsy. This is a surgical procedure to remove and test the lymph nodes closest to the tumor to see if the cancer has started to spread. While it provides vital information, it is an invasive operation that many low-risk patients may n ot need. The MERLIN_001 study validated an innovative tool to solve this problem: a clinicopathologic gene expression profiling (CP-GEP) test. By analyzing the genetic profile of the primary tumor, this test can reliably identify a group of patients who have a very low risk (under 10%) of their cancer having spread to the lymph nodes. The patient impact is profound. The study found the test achieved a negative predictive value of approximately 96%, meaning it is extremely accurate at identifying patients who do not have nodal disease. The adoption of this practice-changing tool could allow a significant number of low-risk patients to safely skip a needless operation altogether. Conclusion: The Wisdom of Questioning The findings from 2025 teach us that medical progress isn't just about questioning old beliefs, but about asking more precise questions. It's no longer enough to ask if a technology like robotics is better, but when and for whom. It's not about whether prehabilitation works, but which specific approach works for a given patient. This demand for nuance and high-quality evidence is what pushes the boundaries of care and ensures the operating room of tomorrow is truly better than the one today. As science continues to advance, which of today's medical certainties will become tomorrow's overturned assumptions? To access additional details, please refer to the Surgical Pioneering Podcast Series application available at the following https://Surgicalpioneer.codeadx.me [https://Surgicalpioneer.codeadx.me] Get full access to Reza Lankarani at lankarani.substack.com/subscribe [https://lankarani.substack.com/subscribe?utm_medium=podcast&utm_campaign=CTA_4]

29. joulu 2025 - 13 min
jakson AI GeneLab Early Detection Chronic Disease kansikuva

AI GeneLab Early Detection Chronic Disease

Reviewed by Dr Reza Lankarani [https://substack.com/profile/331286061-reza-lankarani] 🫆, General Surgeon Founder | Surgical Pioneering Newsletter and Podcast Series Editorial Board Member | Genesis Journal of Surgery and Medicine AI Gene Lab is an innovative medical technology initiative dedicated to enhancing the early detection of chronic illnesses through advanced artificial intelligence. By synthesizing clinical data, medical imaging, and patient lifestyle factors, the organization develops non-invasive screening tools for conditions like diabetes, heart disease, and various cancers. Their diverse portfolio features specialized software designed to predict health risks and suggest personalized treatment dosages, such as insulin levels. Led by experts in bioinformatics and data analysis, the team is currently working to validate these systems alongside clinical professionals to ensure accuracy. Ultimately, the project aims to establish a comprehensive digital health platform that streamlines diagnostics for providers and improves global patient outcomes. Through strategic partnerships, they seek to expand these predictive technologies into the broader realms of telemedicine and international healthcare. 1. Summary AI Gene Lab is an innovative organization focused on improving early detection of chronic and complex diseases through artificial intelligence. Their core mission is to empower healthcare through AI-driven predictive tools, thereby enhancing patient outcomes and easing pressures on healthcare systems. They achieve this by combining medical knowledge with AI and data analysis to provide non-invasive tools for timely diagnosis, informed treatment decisions, and meaningful insights for patients and providers. AI Gene Lab is actively seeking strategic partners, sponsors, and accelerator programs to further its product development, clinical collaborations, and navigate regulatory requirements, with an ultimate goal of global accessibility. 2. Core Mission and Philosophy AI Gene Lab identifies a critical challenge in healthcare: "Many serious conditions are often detected late, reducing treatment effectiveness." Their foundational philosophy is to address this by leveraging AI to facilitate "faster and more accurate risk assessments" through the integration of clinical, imaging, and lifestyle data. The ultimate aim is to "enhance patient outcomes and ease pressures on healthcare systems." 3. Key Offerings: AI-Based Predictive Tools AI Gene Lab's portfolio comprises several AI-based tools, developed and refined with clinical input. These tools are primarily intended for screening and risk assessment and are currently undergoing clinical validation. Diabetes Risk Predictor: This tool "Estimates diabetes risk using hybrid classical machine learning methods trained on established datasets and patient data, analyzing factors such as age, BMI, glucose, insulin, and blood pressure." Insulin Optimal Dose Predictor: Designed to support diabetes management, it "Provides personalized insulin dosing suggestions based on blood glucose, HbA1c, BMI, age, and other health indicators." Rheumatoid Arthritis Risk Tool: Utilizes "clinical symptoms and serological markers like RF and CRP to identify individuals at higher risk, aiding early specialist referral." Skin Cancer Detection AI: Analyzes "skin lesion images to highlight potential malignancies, supporting faster dermatological evaluation." Lumbar Spine Condition Detection: Interprets "MRI scans with AI to help diagnose spinal conditions more quickly, guiding timely treatment." Hybrid ECG AI+++: This comprehensive tool "Combines cardiovascular risk factors, AI-enhanced ECG data, and lifestyle inputs to assess heart disease risk and assist early intervention." 4. Team and Expertise AI Gene Lab boasts an interdisciplinary team with expertise in computational biology, machine learning, and healthcare innovation. The organization is led by: Dr. Sargol Aminnezhad: A bioinformatics postdoctoral researcher at the University of Tehran. Ali Karami: A PhD candidate specializing in AI and data analysis at Bayreuth University, Germany. 5. Future Vision and Strategic Goals Looking forward, AI Gene Lab has ambitious plans for expansion and impact: Comprehensive Digital Health Platform: The organization aims to "develop a comprehensive digital health platform designed to assist healthcare professionals by integrating multiple disease screenings into a single, accessible system." This platform is intended to "support early detection and personalized care, helping to expand the reach of advanced digital health technologies." Global Accessibility: With the right support, AI Gene Lab plans to "extend our platform to telemedicine services, healthcare providers, and global health initiatives, making early disease detection more accessible and effective worldwide." Partnerships and Support: To achieve these goals, AI Gene Lab is actively "seeking strategic partners, sponsors, and accelerator programs to further product development, strengthen clinical collaborations, and navigate regulatory requirements." 6. Key Takeaways and Important Ideas: Focus on Early Detection: AI Gene Lab's core value proposition is the early detection of complex and chronic diseases, aiming to improve treatment efficacy and patient outcomes. AI-Driven, Non-Invasive Tools: The emphasis is on utilizing AI and data analysis to create predictive, non-invasive tools. Clinical Validation is Crucial: The tools are explicitly stated to be "currently undergoing clinical validation alongside medical experts to ensure accuracy and safety," highlighting a commitment to scientific rigor. Interdisciplinary Team: The leadership demonstrates a blend of bioinformatics, AI, and data analysis expertise, crucial for this domain. Scalability and Accessibility: The vision extends beyond individual tools to a comprehensive digital health platform, with a long-term goal of global reach through telemedicine and various healthcare providers. Need for Collaboration: AI Gene Lab openly acknowledges its need for external support (partners, sponsors, accelerators) to achieve its developmental, clinical, and regulatory objectives. 7. Contact Information: For more information, visit: https://aigenelab.com/ [https://aigenelab.com/] Get full access to Reza Lankarani at lankarani.substack.com/subscribe [https://lankarani.substack.com/subscribe?utm_medium=podcast&utm_campaign=CTA_4]

20. joulu 2025 - 5 min
jakson Menopause Care Regulatory Issues Related Directly to Unqualified Corrupted OBGYN Physicians & Cooperations kansikuva

Menopause Care Regulatory Issues Related Directly to Unqualified Corrupted OBGYN Physicians & Cooperations

Authored by Dr Reza Lankarani [https://substack.com/profile/331286061-reza-lankarani], General Surgeon Founder | Surgical Pioneering Newsletter and Podcast Series Editorial Board Member | Genesis Journal of Surgery and Medicine The 20-Year-Old Warning on Menopause Treatment Was Wrong: 4 Surprising Truths About the FDA’s Landmark Decision 1.0 Introduction: The End of an Era of Fear For two decades, a single line in a drug's packaging insert shaped the health decisions of millions of women, often forcing them to endure debilitating menopausal symptoms out of fear. At the center of this concern was the FDA's "black box" warning—the strongest possible safety alert—on Hormone Replacement Therapy (HRT) products, which caused countless women and their doctors to avoid the treatment altogether. Now, in a major policy reversal, the U.S. Department of Health and Human Services (HHS) and the FDA have initiated the removal of these broad warnings. According to HHS Secretary Robert F. Kennedy Jr., the action is about "returning to evidence-based medicine" and correcting the record based on "gold-standard science." Here are the four most impactful takeaways from this landmark decision. 2.0 Takeaway 1: The "Most Dangerous" Warning Was Based on Outdated Science A "Black Box" Warning is the FDA's strongest safety alert, designed to draw immediate attention to "serious, life-threatening, or potentially fatal adverse effects." The presence of this warning on HRT products signaled extreme danger, but the scientific basis for it was flawed. The warnings were largely based on a single study from the early 2000s, the Women's Health Initiative (WHI). Critically, this study involved older women and a hormone formulation that is no longer commonly used today. According to health officials, this led to a significant "distortion of risk" that was inappropriately generalized to the entire menopausal population. As a result, the FDA is now working with manufacturers to remove the following warnings from product labels: * Cardiovascular disease * Breast cancer * Probable dementia 3.0 Takeaway 2: For HRT, Timing Is Everything The FDA is replacing a one-size-fits-all alarm with a more nuanced, evidence-based approach. The core scientific principle driving this new guidance is the "Timing Hypothesis," which posits that the effects of hormone therapy are heavily dependent on a woman's age and how soon she begins treatment after her last period. Experts now agree that starting HRT within this "optimal window" is the key factor that shifts the risk-benefit balance in a woman's favor. The direct, practical application of this hypothesis is the new official FDA labeled recommendation: Initiate systemic HRT within 10 years of menopause onset or before 60 years of age. 4.0 Takeaway 3: Millions of Women Missed Out on Major Health Benefits The "climate of fear and misinformation" created by the outdated warnings had a profound real-world cost. As FDA Commissioner Marty Makary, M.D., M.P.H., stated, the consequences were far-reaching: millions of women have been denied the life-changing benefits of HRT due to a distortion of risk. According to "gold-standard science," the benefits for women who start HRT within the recommended window are significant. They include: * Reduction in All-Cause Mortality: Women may experience a lower risk of death from all causes. * Lower Risk of Cardiovascular Diseases: HRT is associated with a reduced risk of heart disease and stroke. * Reduced Risk of Bone Fractures: Timely HRT initiation helps protect bone density. * Lower Risk of Alzheimer's Disease: HRT is linked to a neuroprotective effect when initiated early. 5.0 Takeaway 4: This Isn't a Blank Check—One Critical Warning Remains This policy change is a targeted correction, not a complete removal of all caution. The FDA is not seeking the removal of every warning associated with HRT, demonstrating a move toward a more precise understanding of risk. Specifically, the boxed warning for endometrial cancer on systemic estrogen-alone products will remain. This risk is clinically significant for women who still have a uterus. However, it is also preventable, as the risk is managed by adding progesterone to the treatment regimen. This isn't a contradiction; it's a validation of the new scientific approach. The goal isn't to declare HRT universally "safe," but to accurately define risk for specific patient profiles—the very definition of personalized medicine. 6.0 Conclusion: A New Conversation About Menopause The FDA's decision is more than a simple label change; it's a formal repudiation of a two-decade-long public health narrative that left millions of women underserved. It signals an end to a fear-based policy and the beginning of a more nuanced approach to menopause care, aligning regulatory guidance with modern scientific consensus. As part of a broader commitment to advancing menopause care, the FDA is also expanding treatment options, approving a generic version of the common estrogen product Premarin and a new non-hormonal treatment for vasomotor symptoms. With the science officially corrected, the critical question is no longer about the risks of the past, but how quickly patients and providers can build the trust needed to have evidence-based conversations about the future of menopause care. To access additional details, please refer to the Surgical Pioneering Podcast Series application available at the following link: https://Surgicalpioneer.codeadx.me [https://Surgicalpioneer.codeadx.me] Get full access to Reza Lankarani at lankarani.substack.com/subscribe [https://lankarani.substack.com/subscribe?utm_medium=podcast&utm_campaign=CTA_4]

11. joulu 2025 - 24 min
jakson Robotic Surgery Precision and Human Empathy kansikuva

Robotic Surgery Precision and Human Empathy

Authored by Dr Reza Lankarani [https://substack.com/profile/331286061-reza-lankarani] 🫆, General Surgeon Founder | Surgical Pioneering Newsletter and Podcast Series Editorial Board Member | Genesis Journal of Surgery and Medicine Robotics in Surgery: A Human-Centric Revolution - Summarize the core message: Robotics aren't replacing surgeons, but empowering them to achieve new heights in patient care, especially as virtual reality training makes robotic surgery more accessible to new generations of medical professionals. - Look ahead to the ethical considerations: equitable access to these advanced technologies, data privacy in a hyper-connected surgical environment, and the ongoing debate around the degree of robotic autonomy in critical decisions. - Conclude with a powerful vision: a future where the synergy of human expertise and robotic precision, augmented by cutting-edge training like virtual reality, truly elevates the standard of medical treatment for everyone. The Future of Surgical Synergy - Imagine the "dream team": surgeons leveraging robotic capabilities as advanced tools, not replacements, with AI acting as a sophisticated co-pilot providing real-time insights. - Explore emerging technologies: advanced haptic feedback allowing surgeons to "feel" tissue through robots, AI-powered diagnostics for pre-surgical planning, and personalized surgical pathways tailored to individual patient anatomy. - Discuss the evolving role of training: equipping future surgeons to master both manual dexterity and advanced robotic control, increasingly through virtual reality training simulations that replicate complex surgical scenarios. The Irreplaceable Human Element - Reassert the surgeon's ultimate role: critical judgment, adaptability to unexpected complications, ethical decision-making, and the crucial ability to interpret nuanced patient responses. - Showcase the "art" of surgery: the nuanced interpretation of patient data, intuition gained through years of experience, and compassionate communication that robots cannot replicate. - Emphasize the unique patient-surgeon bond: empathy, trust built through personal interaction, and the psychological comfort only a human can provide, even with advanced robotic tools. Beyond the Scalpel: What Robots Excel At - Unpack the "superpowers" of surgical robots: tremor elimination, 360-degree articulation, enhanced visualization, and even augmented reality overlays for critical data during surgery. - Dive into specific procedures transformed: prostatectomies, complex cardiac surgeries, and even micro-surgeries that were once impossible, all benefiting from robotic dexterity. - Highlight the data: How robotic assistance demonstrably improves surgical outcomes in measurable ways, showing clearer pathways to better patient care. The Dawn of Robotic Precision - Witness the incredible journey: from early, clunky prototypes to today's sleek surgical robots like the Da Vinci XI, now with enhanced haptic feedback. - Explore the immediate benefits: micron-level precision, reduced incisions, and faster patient recovery times, directly benefiting from advanced robotic capabilities. - Tease the "but": Are we losing something vital in this quest for mechanical perfection, or are we unlocking new human potential? In Summary: The optimal future is not a fully automated OR, but a collaborative cognitive ecosystem, where the surgeon's judgment, experience, and empathy are amplified by a robot's precision and an AI's analytical support. The goal is a synergistic partnership that maximizes patient safety, surgeon well-being, and healthcare system efficiency. To access additional details, please refer to the Surgical Pioneering Podcast Series application available at the following link: https://Surgicalpioneer.codeadx.me [https://Surgicalpioneer.codeadx.me] Get full access to Reza Lankarani at lankarani.substack.com/subscribe [https://lankarani.substack.com/subscribe?utm_medium=podcast&utm_campaign=CTA_4]

8. joulu 2025 - 11 min
Loistava design ja vihdoin on helppo löytää podcasteja, joista oikeasti tykkää
Loistava design ja vihdoin on helppo löytää podcasteja, joista oikeasti tykkää
Kiva sovellus podcastien kuunteluun, ja sisältö on monipuolista ja kiinnostavaa
Todella kiva äppi, helppo käyttää ja paljon podcasteja, joita en tiennyt ennestään.

Valitse tilauksesi

Suosituimmat

Rajoitettu tarjous

Premium

  • Podimon podcastit

  • Ei mainoksia Podimon podcasteissa

  • Peru milloin tahansa

3 kuukautta hintaan 3,99 €
Sitten 7,99 € / kuukausi

Aloita nyt

Premium

20 tuntia äänikirjoja

  • Podimon podcastit

  • Ei mainoksia Podimon podcasteissa

  • Peru milloin tahansa

30 vrk ilmainen kokeilu
Sitten 9,99 € / kuukausi

Aloita maksutta

Premium

100 tuntia äänikirjoja

  • Podimon podcastit

  • Ei mainoksia Podimon podcasteissa

  • Peru milloin tahansa

30 vrk ilmainen kokeilu
Sitten 19,99 € / kuukausi

Aloita maksutta

Vain Podimossa

Suosittuja äänikirjoja

Usein kysytyt kysymykset

Lisää kysymyksiä & vastauksia
Aloita nyt

3 kuukautta hintaan 3,99 €. Sitten 7,99 € / kuukausi. Peru milloin tahansa.